Nazneen Rahman

Last updated

Nazneen Rahman
CBE FMedSci
NationalityBritish
Alma mater
Scientific career
Thesis Localisation and characterisation of the familial tumour gene, FWT1  (1999)
Doctoral advisor Michael Stratton [1]
Website icr.ac.uk/our-research/researchers-and-teams/professor-nazneen-rahman

Sabera Nazneen Rahman CBE FMedSci [2] is a geneticist who specialises in cancer research [3] and is a non-executive director for AstraZeneca. She was previously head of Genetics and Epidemiology at the Institute of Cancer Research. [4] [5]

Contents

Education

Rahman qualified in medicine from University of Oxford in 1991, and completed a PhD in Molecular Genetics in 1999 on the Wilms' tumor susceptibility gene FWT1. [6] [7] She completed her Certificate of Completion of Specialist Training in Clinical Genetics in 2001.

Career and research

She was head of Genetics and Epidemiology at the Institute of Cancer Research, based at the Sir Richard Doll Building in Sutton. She specialises in research into the genetic mechanisms that cause cancer, particularly among groups with a predisposition to pediatric cancers or breast cancer. [8] Through her research, Professor Rahman has provided improved screening and treatment options for NHS patients, and also provides advice on rare cancer genetics to clinicians internationally. [9] She blogs about her work at Harvesting the Genome. [10]

Rahman held a clinical role as head of the cancer genetics service at The Royal Marsden and St George's Hospital in south west London. [1]

Rahman resigned from her position following in October 2018 following upholding on independent investigation of a complaint of systematic bullying spanning 15 years from 44 of her current and former staff and students . [11] Rahman also lost a £3.5-million grant from the Wellcome Trust. [12]

In 2017 Rahman was appointed Non-Executive Director and member of the Science Committee at AstraZeneca Plc. [13]

Awards and honours

Rahman was elected a Fellow of the Academy of Medical Sciences in 2010. Her nomination reads: [2]

Nazneen Rahman is Professor of Human Genetics at the Institute of Cancer Research and Head of the Clinical Genetics Department at the Royal Marsden Hospital. Her research work has been directed towards the mapping, identification and clinical characterisation of human disease genes using genome-wide linkage analysis, positional cloning, candidate gene resequencing, genome-wide association analyses and epigenetic assays. Her primary areas of research are breast cancer susceptibility, childhood cancer susceptibility and human growth disorders. In her relatively short career to date she has already identified and characterised 4 breast cancer predisposition genes and two childhood cancer predisposition genes and two overgrowth genes.

In April 2014, she was named as Britain's third most influential woman in the BBC Woman's Hour power list 2014. [14] In February 2016, she was awarded the Services to Science & Engineering award at the British Muslim Awards. [15]

She was appointed Commander of the Order of the British Empire (CBE) in the 2016 Birthday Honours for services to medical science. [16]

Personal life

Rahman is also a singer-songwriter, with two albums and one EP released. [17]

See also

Related Research Articles

<span class="mw-page-title-main">Wilms' tumor</span> Rare childhood cancer of the kidneys

Wilms' tumor or Wilms tumor, also known as nephroblastoma, is a cancer of the kidneys that typically occurs in children, and occurs most commonly as a renal tumor in child patients. It is named after Max Wilms, the German surgeon (1867–1918) who first described it.

The Institute of Cancer Research is a public research institute and a member institution of the University of London in London, United Kingdom, specialising in oncology. It was founded in 1909 as a research department of the Royal Marsden Hospital and joined the University of London in 2003. It has been responsible for a number of breakthrough discoveries, including that the basic cause of cancer is damage to DNA.

<span class="mw-page-title-main">Walter Bodmer</span> German-born British human geneticist

Sir Walter Fred Bodmer is a German-born British human geneticist.

<span class="mw-page-title-main">Wellcome Sanger Institute</span> British genomics research institute

The Wellcome Sanger Institute, previously known as The Sanger Centre and Wellcome Trust Sanger Institute, is a non-profit British genomics and genetics research institute, primarily funded by the Wellcome Trust.

In molecular biology, SNP array is a type of DNA microarray which is used to detect polymorphisms within a population. A single nucleotide polymorphism (SNP), a variation at a single site in DNA, is the most frequent type of variation in the genome. Around 335 million SNPs have been identified in the human genome, 15 million of which are present at frequencies of 1% or higher across different populations worldwide.

<span class="mw-page-title-main">Mary-Claire King</span> American geneticist

Mary-Claire King is an American geneticist. She was the first to show that breast cancer can be inherited due to mutations in the gene she called BRCA1. She studies human genetics and is particularly interested in genetic heterogeneity and complex traits. She studies the interaction of genetics and environmental influences and their effects on human conditions such as breast and ovarian cancer, inherited deafness, schizophrenia, HIV, systemic lupus erythematosus and rheumatoid arthritis. She has been the American Cancer Society Professor of the Department of Genome Sciences and of Medical Genetics in the Department of Medicine at the University of Washington since 1995.

<span class="mw-page-title-main">Roxana Moslehi</span> Genetic epidemiologist

Roxana Moslehi is an Iranian-born genetic epidemiologist.

<span class="mw-page-title-main">Wilms tumor protein</span> Transcription factor gene involved in the urogenital system

Wilms tumor protein (WT33) is a protein that in humans is encoded by the WT1 gene on chromosome 11p.

<span class="mw-page-title-main">PACRG</span> Protein-coding gene in the species Homo sapiens

Parkin coregulated gene protein is a protein that in humans is encoded by the PACRG gene.

<span class="mw-page-title-main">BAP1</span> Protein-coding gene in the species Homo sapiens

BRCA1 associated protein-1 is a deubiquitinating enzyme that in humans is encoded by the BAP1 gene. BAP1 encodes an 80.4 kDa nuclear-localizing protein with a ubiquitin carboxy-terminal hydrolase (UCH) domain that gives BAP1 its deubiquitinase activity. Recent studies have shown that BAP1 and its fruit fly homolog, Calypso, are members of the polycomb-group proteins (PcG) of highly conserved transcriptional repressors required for long-term silencing of genes that regulate cell fate determination, stem cell pluripotency, and other developmental processes.

Alan Ashworth, FRS is a British molecular biologist, noted for his work on genes involved in cancer susceptibility. He is currently the President of the UCSF Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, a multidisciplinary research and clinical care organisation that is one of the largest cancer centres in the Western United States. He was previously CEO of the Institute of Cancer Research (ICR) in London.

Sir Michael Rudolf Stratton, is a British clinical scientist and the third director of the Wellcome Trust Sanger Institute. He currently heads the Cancer Genome Project and is a leader of the International Cancer Genome Consortium.

Sir Bruce Anthony John Ponder FMedSci FAACR FRS FRCP is an English geneticist and cancer researcher. He is Emeritus Professor of Oncology at the University of Cambridge and former director of the Cancer Research UK Cambridge Institute and of the Cancer Research UK Cambridge Cancer Centre.

Professor Nicholas Dixon Hastie CBE, FRS, FRSE is a British geneticist, and former Director of the MRC Human Genetics Unit at the University of Edinburgh.

<span class="mw-page-title-main">Yusuke Nakamura (geneticist)</span> Medical researcher in Japan

Yusuke Nakamura is a Japanese prominent geneticist and cancer researcher best known for developing Genome-Wide Association Study (GWAS). He is one of the world's pioneers in applying genetic variations and whole genome sequencing, leading the research field of personalized medicine.

<span class="mw-page-title-main">Tim Hubbard</span> Professor of Bioinformatics at Kings College London

Timothy John Phillip Hubbard is a Professor of Bioinformatics at King's College London, Head of Genome Analysis at Genomics England and Honorary Faculty at the Wellcome Trust Sanger Institute in Cambridge, UK. From 1 March 2024, Hubbard became the director of Europe's Life Science Data Infrastructure ELIXIR.

Vanessa Hayes is a geneticist conducting research into cancer genomics and comparative human genomics. She leads a research group at the Garvan Institute of Medical Research in Sydney Australia and holds the Petre Chair of Prostate Cancer Research at the University of Sydney.

<span class="mw-page-title-main">Allan Balmain</span> American academic

Allan Balmain FRS FRSE is Barbara Bass Bakar Distinguished Professor of Cancer Genetics at the University of California, San Francisco (UCSF).

Carolyn J. Brown is a Canadian geneticist and Professor in the Department of Medical Genetics at the University of British Columbia. Brown is known for her studies on X-chromosome inactivation, having discovered the human XIST gene in 1990.

Rosalind Anne Eeles is a Professor of Oncogenetics at the Institute of Cancer Research and clinician at the Royal Marsden NHS Foundation Trust. She is a leader in the field of genetic susceptibility to prostate cancer, and is known for the discovery of 14 genetic variants involved in prostate cancer predisposition. According to ResearchGate, Eeles has published more than 500 articles in peer-reviewed journals, with over 34,000 citations and an h-index of 92. Eeles was elected a Fellow of the Academy of Medical Science in 2012. She was awarded a National Institute for Health Research Senior Investigator Emeritus in 2014.

References

  1. 1 2 "Royal Marsden: Professor Nazneen Rahman". Archived from the original on 2 February 2015.
  2. 1 2 "Professor Nazneen Rahman FMedSci". London: The Academy of Medical Sciences. Archived from the original on 6 May 2014.
  3. ↑ Futreal, P. A.; Coin, L; Marshall, M; Down, T; Hubbard, T; Wooster, R; Rahman, N; Stratton, M. R. (2004). "A census of human cancer genes". Nature Reviews Cancer. 4 (3): 177–83. doi:10.1038/nrc1299. PMC   2665285 . PMID   14993899.
  4. ↑ Burton, P. R.; Clayton, D. G.; Cardon, L. R.; Craddock, N.; Deloukas, P.; Duncanson, A.; Kwiatkowski, D. P.; McCarthy, M. I.; Ouwehand, W. H.; Samani, N. J.; Todd, J. A.; Donnelly, P.; Barrett, J. C.; Burton, P. R.; Davison, D.; Donnelly, P.; Easton, D.; Evans, D.; Leung, H. T.; Marchini, J. L.; Morris, A. P.; Spencer, C. C. A.; Tobin, M. D.; Cardon, L. R.; Clayton, D. G.; Attwood, A. P.; Boorman, J. P.; Cant, B.; Everson, U.; Hussey, J. M. (2007). "Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls". Nature. 447 (7145): 661–678. Bibcode:2007Natur.447..661B. doi:10.1038/nature05911. PMC   2719288 . PMID   17554300.
  5. ↑ Easton, Douglas F.; Pooley, Karen A.; Dunning, Alison M.; Pharoah, Paul D. P.; Thompson, Deborah; Ballinger, Dennis G.; Struewing, Jeffery P.; Morrison, Jonathan; Field, Helen; Luben, Robert; Wareham, Nicholas; Ahmed, Shahana; Healey, Catherine S.; Bowman, Richard; Meyer, Kerstin B.; Haiman, Christopher A.; Kolonel, Laurence K.; Henderson, Brian E.; Le Marchand, Loic; Brennan, Paul; Sangrajrang, Suleeporn; Gaborieau, Valerie; Odefrey, Fabrice; Shen, Chen-Yang; Wu, Pei-Ei; Wang, Hui-Chun; Eccles, Diana; Evans, D. Gareth; Peto, Julian; Fletcher, Olivia; Johnson, Nichola; Seal, Sheila; Stratton, Michael R.; Rahman, Nazneen; Chenevix-Trench, Georgia; Bojesen, Stig E.; Nordestgaard, Børge G.; Axelsson, Christen K.; Garcia-Closas, Montserrat; Brinton, Louise; Chanock, Stephen; Lissowska, Jolanta; Peplonska, Beata; Nevanlinna, Heli; Fagerholm, Rainer; Eerola, Hannaleena; Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun; Hunter, David J.; Hankinson, Susan E.; Cox, David G.; Hall, Per; Wedren, Sara; Liu, Jianjun; Low, Yen-Ling; Bogdanova, Natalia; Schürmann, Peter; Dörk, Thilo; Tollenaar, Rob A. E. M.; Jacobi, Catharina E.; Devilee, Peter; Klijn, Jan G. M.; Sigurdson, Alice J.; Doody, Michele M.; Alexander, Bruce H.; Zhang, Jinghui; Cox, Angela; Brock, Ian W.; MacPherson, Gordon; Reed, Malcolm W. R.; Couch, Fergus J.; Goode, Ellen L.; Olson, Janet E.; Meijers-Heijboer, Hanne; van den Ouweland, Ans; Uitterlinden, André; Rivadeneira, Fernando; Milne, Roger L.; Ribas, Gloria; Gonzalez-Neira, Anna; Benitez, Javier; Hopper, John L.; McCredie, Margaret; Southey, Melissa; Giles, Graham G.; Schroen, Chris; Justenhoven, Christina; Brauch, Hiltrud; Hamann, Ute; Ko, Yon-Dschun; Spurdle, Amanda B.; Beesley, Jonathan; Chen, Xiaoqing; Mannermaa, Arto; Kosma, Veli-Matti; Kataja, Vesa; Hartikainen, Jaana; Day, Nicholas E.; Cox, David R.; Ponder, Bruce A. J. (June 2007). "Genome-wide association study identifies novel breast cancer susceptibility loci". Nature. 447 (7148): 1087–1093. doi:10.1038/nature05887. ISSN   1476-4687. PMC   2714974 .
  6. ↑ Rahman, N.; Arbour, L.; Tonin, P.; Renshaw, J.; Pelletier, J.; Baruchel, S.; Pritchard-Jones, K.; Stratton, M. R.; Narod, S. A. (1996). "Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21". Nature Genetics. 13 (4): 461–463. doi:10.1038/ng0896-461. ISSN   1061-4036. PMID   8696342. S2CID   19914321.
  7. ↑ Rahman, N; Abidi, F; Ford, D; Arbour, L; Rapley, E; Tonin, P; Barton, D; Batcup, G; Berry, J; Cotter, F; Davison, V; Gerrard, M; Gray, E; Grundy, R; Hanafy, M; King, D; Lewis, I; Ridolfi Luethy, A; Madlensky, L; Mann, J; O'Meara, A; Oakhill, T; Skolnick, M; Strong, L; Stratton, M. R. (1998). "Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1". Human Genetics. 103 (5): 547–56. doi:10.1007/pl00008708. PMID   9860296. S2CID   7082835.
  8. ↑ Yost, Shawn; de Wolf, Bas; Hanks, Sandra; Zachariou, Anna; Marcozzi, Chiara; Clarke, Matthew; de Voer, Richarda M.; Etemad, Banafsheh; Uijttewaal, Esther; Ramsay, Emma; Wylie, Harriet (July 2017). "Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation". Nature Genetics. 49 (7): 1148–1151. doi:10.1038/ng.3883. ISSN   1546-1718. PMC   5493194 . PMID   28553959.
  9. ↑ "Institute of Cancer Research: Professor Nazneen Rahman". Archived from the original on 25 August 2014.
  10. ↑ "Harvesting the genome". Archived from the original on 27 May 2017. Retrieved 11 April 2014.
  11. ↑ "Top cancer genetics professor quits job over bullying allegations". The Guardian. 17 July 2018.
  12. ↑ Else, Holly (2018). "Top geneticist loses £3.5-million grant in first test of landmark bullying policy". Nature. 560 (7719): 420. doi:10.1038/d41586-018-06009-9. PMID   30131539. S2CID   256769330.
  13. ↑ "AstraZeneca appoints Professor Nazneen Rahman to its Board of Directors and Science Committee". www.astrazeneca.com. Retrieved 6 December 2019.
  14. ↑ "Woman's Hour Power List 2014 – Game Changers". BBC Radio 4.
  15. ↑ "British Muslim Awards 2016". Asian World. 17 February 2016. Archived from the original on 21 April 2016. Retrieved 1 April 2016.
  16. ↑ "No. 61608". The London Gazette (Supplement). 11 June 2016. p. B9.
  17. ↑ "Rahman's website, NazneenRahman.com".
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.